Cerebral histamine levels are unaffected by MPTP administration in the mouse

This publication has 10 references indexed in Scilit:

• Histochemical localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine oxidation in the mouse brain
  Neuroscience, 1989
• Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
• Factors affecting the stability and separation of biogenic amines and their metabolites
  Journal of Pharmacological Methods, 1987
• Effects of MPTP poisoning on central somatostatin and substance P levels in the mouse
  European Journal of Pharmacology, 1987
• Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine (MPTP) in mice
  Brain Research, 1986
• Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice
  European Journal of Pharmacology, 1986
• Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP
  European Journal of Pharmacology, 1985
• Regional distribution of histamine and tele-methylhistamine in the rat, mouse and guinea-pig brain
  Brain Research, 1983
• Evidence for the presence of a histaminergic neuron system in the rat brain: An immunohistochemical analysis
  Neuroscience Letters, 1983
• BRAIN HISTIDINE DECARBOXYLASE ACTIVITY IN PARKINSON'S DISEASE
  The Lancet, 1983